---
id: task_032
category: general_analysis
char_count: 11221
redaction: org-names-agents-pii-strategy-model-ids-removed
---

# Multi-model debate — internal evaluation task
Mode: debate
is_code_review: false
code_generated_by: llm

## Prompt
````
CONTEXT: example.com homepage for ExampleOrgAI — security-first AI for pharma manufacturing. We are drafting 5 story sections for the homepage. Product Platform = the product. Target audience: VP Quality, CTO, Head of Digital at pharma companies.

DECIDED STRUCTURE (confirmed, not debatable):
1. Hardware-encrypted inference (lead with the problem)
2. Open models on encrypted infrastructure (quality positioning)
3. Models trained for pharma manufacturing (domain expertise)
4. One API for all leading models (flexibility)
5. Free evaluation, no budget approval (last — confidence gesture)

CEO DETAILED DIRECTION per section:

SECTION 1 — MUST lead with the real-world incident:
- Reference: In April 2026, a prominent, extremely security-focused AI provider — a multi-billion-dollar product (~$2.5B revenue) — had its entire codebase leaked online due to their own operational error. Not a hack, not malice — complexity of the setup.
- The point: This is NOT about trusting providers. They clearly put enormous care into security. But complexity defeats intention. The approach should be zero-trust: technologically enforce that data exposure cannot happen, rather than relying on promises and processes.
- DO NOT claim "it can never happen with us" — that's too big a claim
- DO claim: "with our architecture, the probability of similar exposure for your pharma data is orders of magnitude lower"
- Key tech: AMD SEV-SNP, NVIDIA H100 CC, data encrypted during processing, we operate but cannot inspect your prompts or outputs
- Include sovereign deployment: we bring GPUs to your racks, air-gapped
- Attestation: running code matches public repository

SECTION 2 — Quality positioning ("sandbag and overdeliver"):
- DO NOT say "our experience" — that's subjective
- DO say "in our benchmarking, the gap is not major" (or "marginal" — debate which word)
- Then: "A number of independent benchmarks show open models matching or outperforming proprietary on domain-specific tasks"
- Link to service-eval.product.example.com + independent service-eval sources
- Let independent benchmarks make the strong claim, not us

SECTION 3 — Connect to encrypted infrastructure:
- Fine-tuning/retraining can BY DEFINITION only be done with open models — this is not a limitation, it's an advantage
- If they want models smart about their specific tasks, that requires open models
- We offer this as a service: encrypted + tailor-made for their domain + fully Annex 22 ready because we control hardware down to the GPU level
- Reinforce: GMP, Annex 11, 21 CFR Part 11, ALCOA+, Annex 22
- Keep mentioning Annex 22 — we want to own "Annex 22 ready" as our positioning

SECTION 4 — "Fear not, proprietary models also available":
- Framing: if you still want to access proprietary models for some use cases, absolutely possible
- They can see it live at product.example.com — all leading models available
- Proprietary models are by definition NOT encrypted (data goes to provider)
- Customers don't need other providers — one API key covers everything
- What we offer: best of all worlds. Horizontally = all models. Vertically = encrypted + full control of underlying models and hardware
- Annex 22 ready for the encrypted path

SECTION 5 — unchanged from previous draft.

ANNEX 22 STRATEGY: Mention Annex 22 repeatedly across sections. We want to OWN "Annex 22 ready" as our positioning. Not "compliant" (that implies certification), but "ready" (that implies preparedness).

TONE: Factual, confident, honest, not salesy. "We built this, here's what happened in the industry, here's our honest assessment."

TASK: Draft headline + body text (3-5 sentences per section, allow more density than 2-3 since the debate said 2-3 was too constraining). Include "Learn more" link suggestions. Debate the word choice for section 2 ("not major" vs "marginal" vs alternatives).
````

## Response
**JUDGMENT REPORT**

### Finding Group 1: April 2026 Incident Reference (Date + Specificity)
**Reviewers who flagged:** one panel model (4/5), one panel model (5/5), one panel model (5/5). one panel model and one panel model used the date as written. one panel model altered it to 2025.

**Weighing FOR:** Extremely strong. Presenting a future date as a past factual event violates the core "factual, honest, not salesy" directive. In a pharma-regulated audience, this is not a minor editing error — it triggers immediate "this is fabricated FUD" detectors. Even if the *incident pattern* is real, the specific framing ($2.5B, April 2026, entire codebase, operational error) makes the company identifiable and creates unnecessary legal and credibility risk.

**Weighing AGAINST:** Weak. The "placeholder/typo that a human will catch" argument fails because multiple models reproduced it verbatim. The "future-back storytelling" defense is not present in the brief.

**Refutation?** No. The AGAINST arguments do not overcome the honesty violation.

**VERDICT: Confirmed [CRITICAL]**

**Reasoning:** One strong, well-articulated objection from technically rigorous reviewers outweighs models that blindly followed the brief. This cannot ship as written. Change to a real past incident with public evidence or make it explicitly hypothetical.

### Finding Group 2: Architectural Contradiction (Air-gapped Sovereign + One API for Proprietary Models)
**Reviewers who flagged:** one panel model (5/5, clearest articulation). one panel model and one panel model implicitly addressed it by rewriting Section 4 to distinguish boundaries. Others were silent.

**Weighing FOR:** Very strong. one panel model's concrete scenario (CTO gets excited about true air-gapping, then realizes proprietary models require outbound connectivity) is exactly what the target audience (CTO/Head of Digital) will do. An air-gapped system cannot call Provider B/Provider A. This is not nuance — it is a logical impossibility if not explicitly scoped to deployment modes.

**Weighing AGAINST:** Moderate. The "two different deployment models" explanation (cloud vs sovereign) is valid *product* reality, but the brief and most drafts compress them without clarification.

**Refutation?** Partial. The counter-argument correctly identifies it as a *copy* problem rather than a *product* problem, but does not excuse leaving the contradiction in the published homepage.

**VERDICT: Confirmed [BLOCK]**

**Reasoning:** This is the highest-quality finding in the set. Technical accuracy on sovereign deployments is a core value proposition. The copy must explicitly scope proprietary model access to non-air-gapped deployments. Silence from earlier models is not exonerating.

### Finding Group 3: Overclaiming / Imprecise Technical Assertions
This covers: "cannot inspect your prompts or outputs", "running code matches public repository", "by definition only open models" for fine-tuning, "proprietary models are by definition NOT encrypted", and simplistic causal link for Annex 22 readiness.

**Reviewers who flagged:** one panel model (multiple findings at 4-5/5), one panel model (on "orders of magnitude"), one panel model (on Annex 22 repetition and regulatory risk). one panel model and one panel model softened some claims in their drafts.

**Weighing FOR:** Strong on several sub-claims. one panel model's point on "by definition only open models" is particularly rigorous — proprietary providers *do* offer fine-tuning, adapters, and private endpoints. The attestation claim is shorthand that can be challenged by anyone who understands reproducible builds, firmware, and runtime config. "Orders of magnitude" is mathematically unprovable for black-swan events.

**Weighing AGAINST:** Respectable. Homepage copy requires compression. The brief deliberately chose "ready" over "compliant" and rejected "it can never happen." Some of these are directionally correct even if not pedantically precise.

**Refutation?** Partial on most, complete on none. The "it's just homepage shorthand" defense works for tone but does not fully refute the risk of looking technically shallow to the exact audience being targeted.

**VERDICT: Confirmed [WARNING] (with one sub-claim as [CRITICAL])**

**Reasoning:** The "by definition only open models" claim is [CRITICAL] — it is factually loose and easily rebutted. The rest are [WARNING]. These are the exact points sophisticated buyers will probe in diligence. The strongest reviewer (one panel model) mapped them with high precision.

### Finding Group 4: Annex 22 Repetition Strategy
**Reviewers who flagged:** one panel model (3/5), one panel model (4/5), one panel model (4/5).

**Weighing FOR:** Solid. Repetition risks making the page feel like keyword-stuffed marketing rather than the "factual, confident, honest" voice the CEO demands. In Section 4 (proprietary models) it feels particularly forced.

**Weighing AGAINST:** Also strong. In pharma, regulatory keywords *are* the product for VP Quality readers. The brief made a deliberate positioning choice to own the category.

**Refutation?** No — both sides have merit. This is genuinely ambiguous.

**VERDICT: Needs Human Review (Ambiguous)**

**Reasoning:** Both FOR and AGAINST arguments are high quality. The repetition strategy trades narrative elegance for category ownership. A human stakeholder (ideally the VP Quality persona) should decide the final density. Flag for explicit review.

### Finding Group 5: Section 2 Performance Gap Wording ("not major" / "marginal" / "narrow")
**Reviewers who engaged:** All of them. one panel model → "marginal". one panel model → "narrow" (strongest analysis). one panel model → "narrow". one panel model → "often small/in many cases small". one panel model → "not major" (with solid regulatory humility argument). one panel model → "marginal".

**Weighing FOR "narrow"/"often small":** Strongest. It is visually intuitive, avoids both defensiveness and overclaiming, and sets up the independent benchmarks perfectly.

**Weighing FOR "marginal":** Decent but riskier — can read as dismissive in regulated contexts where small differences trigger validation.

**Weighing FOR "not major":** Weakest. Double negative, sounds like a concession.

**Refutation?** Yes — one panel model's analysis effectively refutes the other options.

**VERDICT: Confirmed — Use "narrow" [INFO]**

**Reasoning:** This was the best internal debate across all reviewers. one panel model's breakdown was the highest quality. "Narrow — and on domain-specific tasks, it frequently disappears" is the clearest, most confident, and least defensive phrasing that honors the "sandbag and overdeliver" directive.

---

**Overall Judgment**

The brief contains several high-quality, high-severity issues that multiple strong reviewers surfaced. The two [CRITICAL]/[BLOCK] items (future-dated "real-world" incident and the air-gap/API contradiction) must be resolved before publication. The technical precision cluster is a pattern of optimistic compression that risks credibility with the exact audience the page is targeting.

The word choice and Annex 22 debates are the healthiest parts of the review — they show genuine strategic tension rather than obvious errors.

The drafts from one panel model and the revised version from one panel model are the strongest outputs. They respected the spirit of the brief while removing the landmines. The original brief, taken literally, produces copy that is too aggressive for a regulated pharma audience.
